Chemoinformaics analysis of [(1S,2S,5S)-6,6-DIMETHYL-2-BICYCLO[3.1.1]HEPTANYL]METHYL ACETATE
Molecular Weight | 196.29 | nRot | 2 |
Heavy Atom Molecular Weight | 176.13 | nRig | 19 |
Exact Molecular Weight | 196.146 | nRing | 3 |
Solubility: LogS | -2.198 | nHRing | 0 |
Solubility: LogP | 1.186 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 34.9799 |
nHD | 0 | BPOL | 22.6681 |
QED | 0.764 |
Synth | 3.736 |
Natural Product Likeliness | 1.517 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.593 |
MDCK | 0.00000818 |
BBB | 0.939 |
PPB | 0.540224 |
VDSS | 1.81 |
FU | 0.460403 |
CYP1A2-inh | 0.583 |
CYP1A2-sub | 0.652 |
CYP2c19-inh | 0.106 |
CYP2c19-sub | 0.871 |
CYP2c9-inh | 0.024 |
CYP2c9-sub | 0.583 |
CYP2d6-inh | 0.924 |
CYP2d6-sub | 0.9 |
CYP3a4-inh | 0.291 |
CYP3a4-sub | 0.744 |
CL | 7.415 |
T12 | 0.855 |
hERG | 0.088 |
Ames | 0.955 |
ROA | 0.871 |
SkinSen | 0.289 |
Carcinogencity | 0.499 |
EI | 0.011 |
Respiratory | 0.954 |
NR-Aromatase | 0.073 |
Antiviral | Yes |
Prediction | 0.601586 |